We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Anthera Pharmaceuticals Inc (CE) | USOTC:ANTH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
20-1852016
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification No.)
|
|
25801 Industrial Boulevard, Suite B
|
||
Hayward, California
|
94545
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Large accelerated filer
☐
|
Accelerated filer
☒
|
|
Non-accelerated filer
☐
|
Smaller reporting company
☐
|
|
(Do not check if a smaller reporting company)
|
Emerging growth company
☐
|
|
ANTHERA PHARMACEUTICALS, INC.
|
||
September 22, 2017
|
By:
|
/s/ J. Craig Thompson
|
J. Craig Thompson
|
||
Chief Executive Officer
(Principal Executive Officer)
|
||
September 22, 2017
|
By:
|
/s/ May Liu
|
May Liu
|
||
Senior Vice President, Finance and Administration
|
||
(Principal Accounting Officer)
|
1 Year Anthera Pharmaceuticals (CE) Chart |
1 Month Anthera Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions